Hidradenitis suppurativa (HS) is a painful, chronic inflammatory skin disease associated with substantial individual morbidity and costs to the health care system.
1-7 Hidradenitis suppurativa has an estimated global prevalence of 1% to 4%,
6 but the true prevalence is likely higher, because HS represents an underdiagnosed condition.